CAH - McKesson hits 52-week high; shares up 44% YTD
- McKesson ( NYSE: MCK ) hit a 52-week high on Tuesday of $358.64.
- The wholesale drug distributor is up 44% year-to-date.
- The company was recently buoyed by fiscal 2023 Q1 results that beat on the top and bottom line and also included raising its FY 2023 adjusted diluted EPS outlook .
- McKesson is the top performing wholesale drug distributor of the big three. Cardinal Health ( CAH ) is up ~19% , while AmerisourceBergen ( ABC ) is up ~10% .
- Check out Seeking Alpha contributor Bela Lakos' bullish argument for McKesson ( MCK ).
For further details see:
McKesson hits 52-week high; shares up 44% YTD